{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:21:02Z","timestamp":1791962462966,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T00:00:00Z","timestamp":1280361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> To determine the long\u2010term effects of ruthenium\u2010106 plaque radiation therapy for iris and iridociliary melanomas in terms of tumour regression and complications.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Between 1 November 1997 and 31 December 2007, 36 patients with an iris or iridociliary melanoma were treated with Ruthenium\u2010106 (Ru\u2010106) ophthalmic plaque radiation therapy. The median follow\u2010up was 6.5\u2003years with a range of 2\u201311\u2003years. The mean tumour apex dose was 151.5\u2003Gy. Main outcome measures were local tumour control and radiation\u2010related ocular complications.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The mean age of the patients at the time of treatment was 54\u2003years (range 14\u201382). The tumours had a median largest basal dimension of 4.8\u2003mm (range 3\u201311) and a prominence of 2.3\u2003mm (range 0.8\u20135), with a median involvement of three clock hours (range 1\u20136). The tumours were confined to the iris in 14 patients (39%), extended into the anterior ciliary body in 12 (33%), while the anterior ciliary body tumour extended into the iris in ten patients (28%). Tumours regressed in all patients (100%) with a mean regression of 80% of the original tumour size at 7\u2003years of follow\u2010up. Radiation\u2010related complications included corneal erosions on the first postoperative day in nine patients (25%), cataract in four of 11 patients free of cataract before treatment (36%) and postradiation glaucoma in one patient (3%). Visual acuity of 20\/200 or worse was present in one of 20 patients (5%) at 6\u2003years of follow\u2010up. Local recurrences occurred in two patients (5%), 2 and 5\u2003years after the radiation therapy respectively, and both underwent enucleation. Distant metastases occurred in one of these enucleated patients (3%) 2\u2003years after treatment.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Ru\u2010106 plaque radiation therapy for iris and iridociliary melanoma resulted in good local tumour control and preservation of visual acuity with few and treatable side\u2010effects.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2010.01967.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T12:00:28Z","timestamp":1280404828000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ruthenium plaque radiation therapy for iris and iridociliary melanomas"],"prefix":"10.1111","volume":"90","author":[{"given":"Lubna","family":"Razzaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.E.","family":"Keunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline E.","family":"Schalij\u2010Delfos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Ketelaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.W.","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"23","article-title":"Melanoma of the Iris: report of 72 treated surgically","volume":"6","author":"Arensten JJ","year":"1975","journal-title":"Ophthalmic Surg"},{"key":"e_1_2_5_3_1","first-page":"1","article-title":"Radiodosimetric considerations on ocular brachytherapy with iodine\u2010125 and ruthenium\/rhodium\u2010106","volume":"42","author":"Arnaldo PM","year":"2009","journal-title":"Radiol Bras"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.050"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.08.007"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01007-8"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76028-3"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-004-1183-8"},{"key":"e_1_2_5_9_1","unstructured":"KeizerRJW Tjho\u2010HeslingaRE VerbeekAM&KeunenJEE(2004):Ruthenium Brachytherapy of 24 Iris and Iridociliary Melanomas. International conference of ocular oncology abstract: 69."},{"key":"e_1_2_5_10_1","first-page":"46","article-title":"An anterior segment calculation diagram for 106 Ruth brachytherapy for iris and iridociliary melanomas, the preliminary results of the therapy","volume":"1150","author":"Kuipers N","year":"2002","journal-title":"The Association for Research in Vision and Ophthalmology (ARVO) annual meeting"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rpd\/nci266"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30392-8"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.4.306"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00449-8"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02241-9"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.208"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-3167-3.50040-1"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113150"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00050-0"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/76813976"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1990.tb01821.x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2010.01967.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2010.01967.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:38:35Z","timestamp":1698734315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2010.01967.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1755-3768.2010.01967.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2010.01967.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]},"assertion":[{"value":"2012-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}